Sanofi (SNY) Insider Trading & Ownership $48.28 +0.30 (+0.63%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends There is no recent insider trading on record for Sanofi, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public. Get SNY Insider Trade Alerts Want to know when executives and insiders are buying or selling Sanofi stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Sanofi Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction9/4/2024John JamesU.S. Congress Member (R-MI)Sell$58.53$1,001 - $15,0007/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$51.83$15,001 - $50,0002/27/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$47.85$1,001 - $15,0005/27/2022Earl BlumenauerU.S. Congress Member (D-OR)Buy$55.15$15,001 - $50,0003/16/2022John H. RutherfordU.S. Congress Member (R-FL)Sell$51.90$1,001 - $15,000 (Data available from 1/1/2013 forward) SNY Insider Trading Activity - Frequently Asked Questions What percentage of Sanofi stock is owned by insiders? 1.00% of Sanofi stock is owned by insiders. Learn more on SNY's insider holdings. Which members of congress are trading Sanofi? John James (R-MI) has sold shares of Sanofi in the last year totaling $8,000. Sanofi Key ExecutivesMr. Paul Hudson (Age 57)CEO, Director, Chairman of the Executive Committee, Strategy Committee Compensation: $4.24MMr. François-Xavier Roger (Age 62)Executive VP & CFO Ms. Madeleine Roach (Age 40)Executive VP & Head of Business Operations Mr. Laurent GilhodesPrincipal Accounting Officer and Vice President of Corporate AccountingDr. Josephine FubaraChief Science Officer of Consumer Health CareMr. Thomas Kudsk Larsen (Age 50)Head of Investor Relations Mr. Dante BeccariaGlobal Compliance Officer & VPMr. Roy Papatheodorou (Age 46)Executive VP & General Counsel Mr. Josep CatllaHead of CommunicationsMr. Pierre Chancel (Age 67)Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing More Insider Trading Tools from MarketBeat Related Companies Bristol-Myers Squibb Insider Transactions Pfizer Insider Transactions Biogen Insider Transactions Merck & Co., Inc. Insider Transactions Johnson & Johnson Insider Transactions Novo Nordisk A/S Insider Transactions Novartis Insider Transactions AstraZeneca Insider Transactions GSK Insider Transactions Takeda Pharmaceutical Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:SNY) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNY Stock Alerts